3Wehle MR, Grebstald H. Contraindications to needle aspiration ofa solid renal mass:tumor dissemination by renal needle aspiration[J]. J Urol,1986,136(2):446-448.
4Wahl RL? Harney J, Hutchins G,et al. Imaging of renal cancer u-sing positron emission tomography with 2-deoxy-2-^18 F-fluorodglu-cose:pilot animal and human studies[J]. J Urol, 1991,146(6):1470-1474.
5Marshall FF. Efficiency of ^18F-FDG PET in characterizing renalcancer and detecting distant metastases:a comparison with CT[J]. J Urol,2005,173(3):730.
6Mayauchi T,Brown RS,Grossman HB,et al. Correlation betweenvisualization of primary renal cancer by FDG-PET and histopatho-logical findings[J]. J Nucl Med, 1996,37(suppl):64.
7Kang DE, White RL Jr,Zuger JH,et al. Clinical use of fluorodeox-yglucose F 18 positrion emission tomography for detection of renalcell carcinoma[j]. J Urol,2004,171(5):1806-1809.
